These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31888083)

  • 1. Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules.
    Hosokawa K; Takata T; Sugihara T; Matono T; Koda M; Kanda T; Taniguchi S; Ida A; Mae Y; Yamamoto M; Iyama T; Fukuda S; Isomoto H
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31888083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice.
    Tahara A; Takasu T
    Endocr Res; 2020; 45(2):147-161. PubMed ID: 31955626
    [No Abstract]   [Full Text] [Related]  

  • 3. SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone prevents progression of nonalcoholic steatohepatitis in a type 2 diabetes rodent model.
    Tahara A; Takasu T
    Physiol Rep; 2019 Nov; 7(22):e14286. PubMed ID: 31782258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model.
    Morishita A; Tadokoro T; Fujihara S; Iwama H; Oura K; Fujita K; Tani J; Takuma K; Nakahara M; Shi T; Haba R; Okano K; Nishiyama A; Ono M; Himoto T; Masaki T
    PLoS One; 2022; 17(2):e0261310. PubMed ID: 35192632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice.
    Honda Y; Imajo K; Kato T; Kessoku T; Ogawa Y; Tomeno W; Kato S; Mawatari H; Fujita K; Yoneda M; Saito S; Nakajima A
    PLoS One; 2016; 11(1):e0146337. PubMed ID: 26731267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats.
    Hayashizaki-Someya Y; Kurosaki E; Takasu T; Mitori H; Yamazaki S; Koide K; Takakura S
    Eur J Pharmacol; 2015 May; 754():19-24. PubMed ID: 25701721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
    PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis.
    Rahman K; Liu Y; Kumar P; Smith T; Thorn NE; Farris AB; Anania FA
    Lab Invest; 2016 Aug; 96(8):895-908. PubMed ID: 27239734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of Ipragliflozin, a Sodium-glucose Cotransporter 2 Inhibitor, on a Non-alcoholic Steatohepatitis Mouse Model.
    Yamane M; Matono T; Okano JI; Nagahara R; Matsuki Y; Okamoto T; Miyoshi KI; Sugihara T; Nagahara T; Koda M; Isomoto H
    Yonago Acta Med; 2019 Mar; 62(1):30-35. PubMed ID: 30962742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone on fluid retention in type 2 diabetic mice with NASH.
    Tahara A
    Eur J Pharmacol; 2021 Jun; 901():174076. PubMed ID: 33798599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice.
    Zhang N; Lu Y; Shen X; Bao Y; Cheng J; Chen L; Li B; Zhang Q
    Pharmacology; 2015; 95(3-4):173-80. PubMed ID: 25896720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bicyclol attenuates tetracycline-induced fatty liver associated with inhibition of hepatic ER stress and apoptosis in mice.
    Yao XM; Li Y; Li HW; Cheng XY; Lin AB; Qu JG
    Can J Physiol Pharmacol; 2016 Jan; 94(1):1-8. PubMed ID: 26640164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin reduces the risk of chronic kidney damage in mice with nonalcoholic steatohepatitis by modulating endoplasmic reticulum stress and MAPK signaling.
    Afrin MR; Arumugam S; Rahman MA; Karuppagounder V; Harima M; Suzuki H; Miyashita S; Suzuki K; Ueno K; Yoneyama H; Watanabe K
    Int Immunopharmacol; 2017 Aug; 49():161-167. PubMed ID: 28595079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bicyclol alleviates high-fat diet-induced hepatic ER stress- and autophagy-associated non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in mice.
    Jia S; Jin L; Cheng X; Wu J; Yao X; Shao J; Zhang C; Cen D; Cheng B; Wang J; Chen L; Yao X
    Drug Dev Ind Pharm; 2022 Jun; 48(6):247-254. PubMed ID: 35875932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.
    Muraki Y; Makita Y; Yamasaki M; Amano Y; Matsuo T
    Biochem Biophys Res Commun; 2017 May; 486(3):632-638. PubMed ID: 28322783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients.
    Mueller M; Castro RE; Thorell A; Marschall HU; Auer N; Herac M; Rodrigues CMP; Trauner M
    Liver Int; 2018 Mar; 38(3):523-531. PubMed ID: 28853202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
    PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
    Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
    Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats.
    Tahara A; Kurosaki E; Yokono M; Yamajuku D; Kihara R; Hayashizaki Y; Takasu T; Imamura M; Li Q; Tomiyama H; Kobayashi Y; Noda A; Sasamata M; Shibasaki M
    J Pharm Pharmacol; 2014 Jul; 66(7):975-87. PubMed ID: 24533859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoplasmic reticulum stress inhibition attenuates hypertensive chronic kidney disease through reduction in proteinuria.
    Mohammed-Ali Z; Lu C; Marway MK; Carlisle RE; Ask K; Lukic D; Krepinsky JC; Dickhout JG
    Sci Rep; 2017 Feb; 7():41572. PubMed ID: 28148966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.